CXCL8 and neoplasm: The same group further found that treatment with reparixin, a CXCR1 and CXCR2 inhibitor, abrogated the trafficking of MDSCs in immunocompromised HT29 tumor-bearing mice that underwent IL-8 hydrodynamic gene transfer.